RSSS Rasio silihan jangka dawa marang modal researchsolutions.com

Tandha merek researchsolutions.com (RSSS)

The price history of Research Solutions (RSSS) reflects the dynamics of a company with a metric of 0.00. The business leverages the global trend of healthcare digitalization, which completely offsets macroeconomic threats. Growth is driven by partnerships with pharma behemoths and publishers to create joint research ecosystems. Scaling efficiency across thousands of centers is achieved through the automation of cloud data access while maintaining a minimal developer headcount.

RSSS - Utang jangka dawa marang ekuitas Research Solutions ing rentang 04.07.2022 - 27.10.2026
Barang utama researchsolutions.com

The long-term debt-to-equity ratio measures the proportion of liabilities with a maturity exceeding one year relative to shareholders' equity, determining financial stability and the extent of the business's reliance on external borrowing. By analyzing this long-term debt-to-equity ratio chart, an investor can assess the ability of Research Solutions (RSSS) to withstand academic budget cuts and competition from open data without the risk of default.

Karo sapa Research Solutions saingan

Rasio tanggungan utang jangka dawa marang modal Veeva Systems (VEEV)|Rasio utang jangka dawa marang ekuitas Doximity Corp|Rasio silihan jangka dawa marang modal HealthEquity Building HQY|Rasio utang jangka dawa marang ekuitas Waystar Holding Corp.|corvel.com - Koefisien utang jangka dawa marang modal|PRVA: Utang jangka dawa marang ekuitas|HURN - Rasio utang jangka dawa marang ekuitas|Utang jangka dawa marang modal CERT|Omnicell Health (OMCL) - Kewajiban jangka dawa marang modal|Utang jangka dawa marang modal GoodRx Holdings, Inc. (GDRX)|Rasio utang jangka dawa marang modal SDGR|Phreesia (PHR) - Utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal Omada Health, Inc. (OMDA)|EVH: Utang jangka dawa marang modal|HealthStream Learning - Kewajiban jangka dawa marang modal|Utang jangka dawa marang ekuitas DH (Definitive Healthcare)|CCSI - Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang modal AGL|Absci Corp (ABSI) - Kewajiban jangka dawa marang modal|SY (SoYoung) - Utang jangka dawa marang modal|Utang jangka dawa marang modal NRC|Spok Holdings, Inc. (SPOK) - Utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal optimizerx.com (OPRX)|TruBridge - Utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas Simulations Plus Inc SLP|Utang jangka dawa marang modal SOPHiA GENETICS S.A. (SOPH)|Health Catalyst Inc (HCAT) - Koefisien utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas carecloud.com CCLD|DLHC (DLH Holdings) - Koefisien utang jangka dawa marang modal|ONMD: Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka dawa marang modal SCNX|Healthcare Triangle Corp - Utang jangka dawa marang ekuitas|Kewajiban jangka dawa marang modal ISPC (ispecimen.com)|Utang jangka dawa marang ekuitas Bullfrog AI BFRG|WORX - Utang jangka dawa marang ekuitas|MSP Recovery - Rasio utang jangka dawa marang ekuitas|iCoreConnect Inc. (ICCT) - Utang jangka dawa marang modal|MEDS - Rasio utang jangka dawa marang ekuitas|Orgenesis Corporation (ORGS) - Rasio silihan jangka dawa marang modal|RCM: Utang jangka dawa marang modal|Rasio tanggungan utang jangka dawa marang modal SHCR|Streamline Health - Utang jangka dawa marang ekuitas|Kewajiban jangka dawa marang modal SYRA (Syra Health Corp)|AMEH - Utang jangka dawa marang ekuitas|Model N Corporation - Rasio utang jangka dawa marang modal|Utang jangka dawa marang ekuitas NXGN (NextGen Healthcare)